According to the TechSci Research report titled "United States Hereditary Angioedema Therapeutics Market – By Region, Competition, Forecast and Opportunities, 2029F," the U.S. market for Hereditary Angioedema (HAE) therapeutics is projected to reach USD 846.80 million in 2023, with an anticipated Compound Annual Growth Rate (CAGR) of 7.12% during the forecast period from 2025 to 2029. HAE...